Publication | Closed Access
Efficacy and safety of glecaprevir/pibrentasvir in renally impaired patients with chronic HCV infection
62
Citations
27
References
2019
Year
This Phase 3 clinical trial was funded by AbbVie and registered with clinicaltrials.gov as NCT03069365 (EXPEDITION-5).
| Year | Citations | |
|---|---|---|
Page 1
Page 1